These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19695556)

  • 1. BARI 2D: headlines are not enough.
    King SB
    JACC Cardiovasc Interv; 2009 Aug; 2(8):809-10. PubMed ID: 19695556
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased Hazard of Myocardial Infarction With Insulin-Provision Therapy in Actively Smoking Patients With Diabetes Mellitus and Stable Ischemic Heart Disease: The BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Trial.
    Khan AA; Chung MJ; Novak E; Brown DL
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28903941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The BARI 2D study].
    Mafrici A; Briguori C
    G Ital Cardiol (Rome); 2010 Oct; 11(10):711-7. PubMed ID: 21246772
    [No Abstract]   [Full Text] [Related]  

  • 4. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
    Tamis-Holland JE; Lu J; Korytkowski M; Magee M; Rogers WJ; Lopes N; Mighton L; Jacobs AK;
    J Am Coll Cardiol; 2013 Apr; 61(17):1767-76. PubMed ID: 23500245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of the BARI 2D and COURAGE trials of coronary artery disease.
    Kuller LH
    Coron Artery Dis; 2010 Nov; 21(7):391-6. PubMed ID: 20634693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary prevention of ischaemic cardiac events.
    Sudlow C; Lonn E; Pignone M; Ness A; Rihal C
    Clin Evid; 2002 Jun; (7):124-60. PubMed ID: 12230641
    [No Abstract]   [Full Text] [Related]  

  • 7. Planning and Conducting the ISCHEMIA Trial.
    Maron DJ; Harrington RA; Hochman JS
    Circulation; 2018 Oct; 138(14):1384-1386. PubMed ID: 30354348
    [No Abstract]   [Full Text] [Related]  

  • 8. Pioglitazone to reduce restenosis after bare-metal stent placement?
    Nissen SE
    JACC Cardiovasc Interv; 2009 Jun; 2(6):532-3. PubMed ID: 19539257
    [No Abstract]   [Full Text] [Related]  

  • 9. Coronary artery bypass graft surgery (CABG) for patients with diabetes and multivessel coronary artery disease: identifying patients who would benefit with CABG and understanding the potential mechanisms involved.
    Greason KL; Schaff HV
    Coron Artery Dis; 2010 Nov; 21(7):402-6. PubMed ID: 20706113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revascularization vs. Medical Therapy in Stable Ischemic Heart Disease.
    Weiss S; Weintraub W
    Prog Cardiovasc Dis; 2015; 58(3):299-305. PubMed ID: 26206111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of diabetes mellitus in patients with cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Goldfine AB; Fonseca V
    Circulation; 2010 Jun; 121(22):2447-9. PubMed ID: 20530022
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular clinical trials in patients with diabetes mellitus: lessons from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study.
    Solomon SD
    Circulation; 2010 Jun; 121(22):2453-5. PubMed ID: 20530024
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.
    Dagenais GR; Lu J; Faxon DP; Kent K; Lago RM; Lezama C; Hueb W; Weiss M; Slater J; Frye RL;
    Circulation; 2011 Apr; 123(14):1492-500. PubMed ID: 21444887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D).
    Schwartz L; Kip KE; Alderman E; Lu J; Bates ER; Srinivas V; Bach RG; Mighton LD; Feit F; King S; Frye RL;
    Am J Cardiol; 2009 Mar; 103(5):632-8. PubMed ID: 19231325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes for ischemic heart disease in dialysis-dependent patients.
    Yeates A; Hawley C; Mundy J; Pinto N; Haluska B; Shah P
    Asian Cardiovasc Thorac Ann; 2012 Jun; 20(3):281-91. PubMed ID: 22718716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial.
    Sobel BE
    Coron Artery Dis; 2010 May; 21(3):189-98. PubMed ID: 20308880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRO: Preoperative coronary revascularization in high-risk patients undergoing vascular surgery.
    Landesberg G; Mosseri M
    Anesth Analg; 2008 Mar; 106(3):759-63. PubMed ID: 18292414
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.
    Holper EM; Addo T
    Coron Artery Dis; 2010 Nov; 21(7):397-401. PubMed ID: 20634692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revascularization trumps medicine for patients with type 2 diabetes mellitus and chronic angina (or does it?).
    Marso SP
    Circulation; 2011 Apr; 123(14):1489-91. PubMed ID: 21444884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.